The increasing product launches and approvals are expected to drive the market growth over the forecast period.
For instance, in August 2021, Terumo Aortic had received the U.S Food and Drug Administration (FDA) approval for Relay Pro Thoracic Stent-Graft System for the sale in the U.S for treatment of patients with thoracic aortic aneurysms (TAA) and penetrating atherosclerotic ulcers (PAUs).
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients